Literature DB >> 8257149

Augmentation of murine tumor necrosis factor production by amphotericin B in vitro and in vivo.

Y Tokuda1, M Tsuji, M Yamazaki, S Kimura, S Abe, H Yamaguchi.   

Abstract

Murine peritoneal macrophages were preincubated with amphotericin B (AMPH) and were then stimulated with bacterial lipopolysaccharide or streptococcal preparation (OK432). These macrophages produced a large amount of tumor necrosis factor. When administered to mice, the priming activity of amphotericin B for tumor necrosis factor production in vivo was also observed.

Entities:  

Mesh：

Substances：

Year:  1993        PMID： 8257149      PMCID： PMC192255          DOI： 10.1128/AAC.37.10.2228

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN： 0066-4804            Impact factor:   5.191


  13 in total

1.  Growth inhibition of Candida albicans by human polymorphonuclear neutrophils: activation by interferon-gamma and tumor necrosis factor.

Authors:  J Y Djeu; D K Blanchard; D Halkias; H Friedman
Journal:  J Immunol       Date:  1986-11-01       Impact factor: 5.422

2.  Amphotericin B induces tumor necrosis factor production by murine macrophages.

Authors:  J K Chia; M Pollack
Journal:  J Infect Dis       Date:  1989-01       Impact factor: 5.226

3.  Effects of antifungal agents and gamma interferon on macrophage cytotoxicity for fungi and tumor cells.

Authors:  J R Perfect; D L Granger; D T Durack
Journal:  J Infect Dis       Date:  1987-08       Impact factor: 5.226

4.  Release of tumor necrosis factor by human polymorphonuclear leukocytes.

Authors:  J Y Djeu; D Serbousek; D K Blanchard
Journal:  Blood       Date:  1990-10-01       Impact factor: 22.113

5.  In vivo activation of macrophage oxidative burst activity by cytokines and amphotericin B.

Authors:  J E Wolf; S E Massof
Journal:  Infect Immun       Date:  1990-05       Impact factor: 3.441

6.  Passive immunization against cachectin/tumor necrosis factor protects mice from lethal effect of endotoxin.

Authors:  B Beutler; I W Milsark; A C Cerami
Journal:  Science       Date:  1985-08-30       Impact factor: 47.728

7.  Protective immunity induced by low-virulence Candida albicans: cytokine production in the development of the anti-infectious state.

Authors:  A Vecchiarelli; E Cenci; M Puliti; E Blasi; P Puccetti; A Cassone; F Bistoni
Journal:  Cell Immunol       Date:  1989-12       Impact factor: 4.868

8.  In vitro tumor necrosis factor induction assay for analysis of febrile toxicity associated with amphotericin B preparations.

Authors:  J K Chia; E J McManus
Journal:  Antimicrob Agents Chemother       Date:  1990-05       Impact factor: 5.191

9.  Activation of human polymorphonuclear neutrophil functions by interferon-gamma and tumor necrosis factors.

Authors:  M R Shalaby; B B Aggarwal; E Rinderknecht; L P Svedersky; B S Finkle; M A Palladino
Journal:  J Immunol       Date:  1985-09       Impact factor: 5.422

10.  Local induction of a cytotoxic factor in a murine tumour by systemic administration of an antitumour polysaccharide, MGA.

Authors:  K Takahashi; Y Watanuki; M Yamazaki; S Abe
Journal:  Br J Cancer       Date:  1988-02       Impact factor: 7.640
View more
  19 in total

1.  Enhancement of nitric oxide synthesis by macrophages represents an additional mechanism of action for amphotericin B.

Authors:  N Mozaffarian; J W Berman; A Casadevall
Journal:  Antimicrob Agents Chemother       Date:  1997-08       Impact factor: 5.191

2.  Effects of MS-8209, an amphotericin B derivative, on tumor necrosis factor alpha synthesis and human immunodeficiency virus replication in macrophages.

Authors:  P Clayette; M Martin; V Beringue; N Dereuddre-Bosquet; K T Adjou; M Seman; D Dormont
Journal:  Antimicrob Agents Chemother       Date:  2000-02       Impact factor: 5.191

3.  Antigenic Hsp70-peptide upregulate altered cell surface MHC class I expression in TAMs and increases anti-tumor function in Dalton's lymphoma bearing mice.

Authors:  Pramod Kumar Gautam; Arbind Acharya
Journal:  Tumour Biol       Date:  2014-11-28

4.  Reduction of no synthase expression and tumor necrosis factor alpha production in macrophages by amphotericin B lipid carriers.

Authors:  M Larabi; P Legrand; M Appel; S Gil; M Lepoivre; J Devissaguet; F Puisieux; G Barratt
Journal:  Antimicrob Agents Chemother       Date:  2001-02       Impact factor: 5.191

Review 5.  Immunomodulating effects of antibiotics: literature review.

Authors:  B Van Vlem; R Vanholder; P De Paepe; D Vogelaers; S Ringoir
Journal:  Infection       Date:  1996 Jul-Aug       Impact factor: 3.553

6.  Late treatment with polyene antibiotics can prolong the survival time of scrapie-infected animals.

Authors:  R Demaimay; K T Adjou; V Beringue; S Demart; C I Lasmézas; J P Deslys; M Seman; D Dormont
Journal:  J Virol       Date:  1997-12       Impact factor: 5.103

7.  Real-time reverse transcription-PCR quantification of cytokine mRNA expression in golden Syrian hamster infected with Leishmania infantum and treated with a new amphotericin B formulation.

Authors:  S Rama Iñiguez; M A Dea-Ayuela; J A Sanchez-Brunete; J J Torrado; J M Alunda; F Bolas-Fernández
Journal:  Antimicrob Agents Chemother       Date:  2006-04       Impact factor: 5.191

8.  Anticryptococcal effect of amphotericin B is mediated through macrophage production of nitric oxide.

Authors:  M Tohyama; K Kawakami; A Saito
Journal:  Antimicrob Agents Chemother       Date:  1996-08       Impact factor: 5.191

9.  Immunoenhancement combined with amphotericin B as treatment for experimental visceral leishmaniasis.

Authors:  Henry W Murray; Elaine B Brooks; Jennifer L DeVecchio; Frederick P Heinzel
Journal:  Antimicrob Agents Chemother       Date:  2003-08       Impact factor: 5.191

Review 10.  Optimizing efficacy of Amphotericin B through nanomodification.

Authors:  Gillian Barratt; Stéphane Bretagne
Journal:  Int J Nanomedicine       Date:  2007
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.